Cefan Zhou

3.8k total citations · 1 hit paper
38 papers, 758 citations indexed

About

Cefan Zhou is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Cefan Zhou has authored 38 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Epidemiology and 10 papers in Cancer Research. Recurrent topics in Cefan Zhou's work include Autophagy in Disease and Therapy (12 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). Cefan Zhou is often cited by papers focused on Autophagy in Disease and Therapy (12 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). Cefan Zhou collaborates with scholars based in China, Canada and United Kingdom. Cefan Zhou's co-authors include Jingfeng Tang, Xing‐Zhen Chen, Marek Michalak, Declan W. Ali, Yuan Huang, Wenying Qin, Yanan Yan, Yefu Wang, Rui Zhang and Xuewen Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Cefan Zhou

35 papers receiving 755 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes

2020 270 citations Cefan Zhou, Wenying Qin et al. profile →

Peers

Cefan Zhou

EPIDE

ONCOL

PRM

Xiao Zhi China

Xiaohui Pan China

Lucia D’Antona Italy

Seon Rang Woo South Korea

Qiao‐Li Lv China

Jiawei Shou China

Jiansha Li China

Liangkun You China

Shanshan Deng United States

Xiao Zhi China

Cefan Zhou

588 ×1.1

275 ×0.8

118 ×0.9

EPIDE

216 ×1.7

ONCOL

47 ×0.6

PRM

Citations per year, relative to Cefan Zhou Cefan Zhou (= 1×) peers Xiao Zhi

Countries citing papers authored by Cefan Zhou

Since Specialization

Citations

This map shows the geographic impact of Cefan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cefan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cefan Zhou more than expected).

Fields of papers citing papers by Cefan Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cefan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cefan Zhou. The network helps show where Cefan Zhou may publish in the future.

Co-authorship network of co-authors of Cefan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Cefan Zhou. A scholar is included among the top collaborators of Cefan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cefan Zhou. Cefan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Mengmeng, Rui Zhang, Shuai Xiao, et al.. (2025). Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer. Journal of Advanced Research. 78. 285–306. 4 indexed citations

Xiao, Shuai, Meng Liao, D. Song, et al.. (2025). Role of Ubiquitin-regulated EMT in Cancer Metastasis and Chemoresistance. International Journal of Biological Sciences. 21(14). 6081–6112. 1 indexed citations

Zhang, Rui, Shuai Xiao, Dong Guo, et al.. (2024). The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment. International Journal of Molecular Sciences. 25(24). 13334–13334. 2 indexed citations

Wang, Yi-Fang, Xiaoling Deng, Rui Zhang, et al.. (2024). The TRPV6 Calcium Channel and Its Relationship with Cancer. Biology. 13(3). 168–168. 4 indexed citations

Zhang, Rui, Shicheng Liu, Vincenzo Torraca, et al.. (2024). ILKAP Promotes the Metastasis of Hepatocellular Carcinoma Cells by Inhibiting β‐Catenin Degradation and Enhancing the WNT Signaling Pathway. Advanced Biology. 8(5). e2300117–e2300117. 1 indexed citations

Liu, Qinfeng, Xin Zhang, Rui Zhang, et al.. (2024). TRPM channels in human cancers: regulatory mechanism and therapeutic prospects. Biomarker Research. 12(1). 152–152. 1 indexed citations

Zhang, Rui, Hao Lyu, Shuai Xiao, et al.. (2024). LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. International Journal of Biological Sciences. 20(7). 2698–2726. 5 indexed citations

Lyu, Hao, Qian Ouyang, Rui Zhang, et al.. (2024). Insights into the Roles of Epigenetic Modifications in Ferroptosis. Biology. 13(2). 122–122. 7 indexed citations

Yuan, Wenbin, Rui Zhang, Shuai Xiao, et al.. (2024). Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies. Cell Death Discovery. 10(1). 327–327. 8 indexed citations

10.

Yuan, Wenbin, Wei Liu, Xingyu Chen, et al.. (2024). Screening and identification of miRNAs negatively regulating FAM83A/Wnt/β-catenin signaling pathway in non-small cell lung cancer. Scientific Reports. 14(1). 17394–17394. 3 indexed citations

11.

Lyu, Hao, Jiahui Zhang, Yuan Huang, et al.. (2023). Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma. Biology. 12(2). 319–319. 5 indexed citations

12.

Liu, Lei, Yuan Huang, Rui Zhang, et al.. (2023). Membrane Curvature: The Inseparable Companion of Autophagy. Cells. 12(8). 1132–1132. 2 indexed citations

13.

Xiao, Shuai, Yeping Yu, Rui Zhang, et al.. (2023). Cellular senescence: a double-edged sword in cancer therapy. Frontiers in Oncology. 13. 1189015–1189015. 50 indexed citations

14.

Yuan, Wenbin, Rui Zhang, Hao Lyu, et al.. (2023). Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(7). 119537–119537. 25 indexed citations

15.

Liu, Wei, Yuan Huang, Hao Lyu, et al.. (2023). The role of N-glycosylation modification in the pathogenesis of liver cancer. Cell Death and Disease. 14(3). 222–222. 29 indexed citations

16.

Tian, Rui, Lin Yuan, Yuan Huang, et al.. (2023). Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine. Frontiers in Pharmacology. 13. 1053602–1053602. 12 indexed citations

17.

Zhou, Cefan, Xueying Dong, Ming Wang, et al.. (2022). Phosphorylated STYK1 restrains the inhibitory role of EGFR in autophagy initiation and EGFR-TKIs sensitivity. SHILAP Revista de lepidopterología. 1(4). 100045–100045. 8 indexed citations

18.

Huang, Yuan, Zhenhua Jia, Weiwei Zhao, et al.. (2020). Transient Receptor Potential Melastatin 8 (TRPM8) Channel Regulates Proliferation and Migration of Breast Cancer Cells by Activating the AMPK-ULK1 Pathway to Enhance Basal Autophagy. Frontiers in Oncology. 10. 573127–573127. 32 indexed citations

19.

Zhou, Cefan, Ming Wang, Jing Yang, et al.. (2019). Integral membrane protein 2A inhibits cell growth in human breast cancer via enhancing autophagy induction. Cell Communication and Signaling. 17(1). 105–105. 26 indexed citations

20.

Zhou, Cefan, Yi Zhang, Jun Dai, et al.. (2016). Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment. Scientific Reports. 6(1). 22066–22066. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact